Microbion Corporation
CEO: Karim Lalji
Founder, President & CSO: Brett Baker
Microbion’s lead drug candidate, pravibismane, is the first known therapeutic with a novel mechanism of action and combined potencyagainst multi-drug resistant Gram-negative and Gram-positive bacteria/superbugsand resistant fungal pathogenswith the ability to eradicate bacterial biofilms.